SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10678137
Source:
http://linkedlifedata.com/resource/pubmed/id/10678137
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002395
,
umls-concept:C0006935
,
umls-concept:C0030705
,
umls-concept:C0039225
,
umls-concept:C1522326
pubmed:issue
6
pubmed:dateCreated
2000-5-1
pubmed:abstractText
To compare the efficacy and safety between huperzine-A (Hup) in capsules and tablets for treating patients with Alzheimer disease (AD).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10678137
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8100330
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids
,
http://linkedlifedata.com/resource/pubmed/chemical/Capsules
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipid Peroxides
,
http://linkedlifedata.com/resource/pubmed/chemical/Sesquiterpenes
,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxide Dismutase
,
http://linkedlifedata.com/resource/pubmed/chemical/Tablets
,
http://linkedlifedata.com/resource/pubmed/chemical/huperzine A
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0253-9756
pubmed:author
pubmed-author:ChengR YRY
,
pubmed-author:FengBB
,
pubmed-author:LiJ XJX
,
pubmed-author:QuZ WZW
,
pubmed-author:SaxH JHJ
,
pubmed-author:SeyLL
,
pubmed-author:UhlJ MJM
,
pubmed-author:WangG QGQ
,
pubmed-author:XuW AWA
,
pubmed-author:YUS TST
,
pubmed-author:YangR MRM
,
pubmed-author:ZhongX SXS
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
486-90
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:10678137-Aged
,
pubmed-meshheading:10678137-Aged, 80 and over
,
pubmed-meshheading:10678137-Alkaloids
,
pubmed-meshheading:10678137-Alzheimer Disease
,
pubmed-meshheading:10678137-Capsules
,
pubmed-meshheading:10678137-Cholinesterase Inhibitors
,
pubmed-meshheading:10678137-Double-Blind Method
,
pubmed-meshheading:10678137-Female
,
pubmed-meshheading:10678137-Humans
,
pubmed-meshheading:10678137-Lipid Peroxides
,
pubmed-meshheading:10678137-Male
,
pubmed-meshheading:10678137-Middle Aged
,
pubmed-meshheading:10678137-Prospective Studies
,
pubmed-meshheading:10678137-Sesquiterpenes
,
pubmed-meshheading:10678137-Superoxide Dismutase
,
pubmed-meshheading:10678137-Tablets
pubmed:year
1999
pubmed:articleTitle
Huperzine-A in capsules and tablets for treating patients with Alzheimer disease.
pubmed:affiliation
Zhejiang Mental Health Institute, Hangzhou, China. xusisun@telekbird.com.cn
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study